📢This is our last post on X
You can still find us on:
* Mastodon: https://t.co/ckjIFD2jmo
* BlueSky: https://t.co/okow3XFe9S
* Facebook: https://t.co/YjZvNZenPg
* Instagram: https://t.co/g4GZIjo4Gl
Update!
Oxford University Press (OUP) has reached this year's publication quota
This means that publication costs are no longer covered centrally!
Read here about alternative routes to Open Access: https://t.co/3fbYTjYuE5
Did you know that information specialists from the Medical Library often contribute as co-authors to systematic and scoping reviews?
Reviews we've contributed to: https://t.co/mTqdUcVJ4L
Interested? Learn more: https://t.co/clBfdVCynl
Message for UMCG authors:
the limit of the open access deal with the publisher LWW is reached.
If your manuscript is accepted by LWW, Open Access costs will no longer be covered! You will receive an invoice. https://t.co/kj5sz0GoSI
UMCG authors please note:
We expect to soon reach the quota for Open Access publishing for a number of major publishers: LWW,Taylor & Francis, Oxford UP, American Chemical Society, Springer.
Read more:
https://t.co/3fbYTjYuE5
Many UMCG employees use #BioRender: https://t.co/T0EOO6Uif4
You can use it to create biomedical illustrations.
But beware: this is a commercial service. The #copyright of the images rests with BioRender and not with you or the UMCG!
Read more: https://t.co/9zqdXWWsuf
Register for our Lunch Session:
'Are your profile pages up-to-date?'
📅 Thursday 10 April 2025, 12.00-13.00
📍 Medical Library location Hanzeplein (Y4)
▶️ Note: only for UMCG employees!
🍽️ Lunch is provided
More info & register: https://t.co/gKJMxfVU2B
The UMCG has received a grant from Open Science NL, to further advance our goals of supporting UMCG researchers in FAIRifying their data and software.
The FAIR principles are: Findable, Accessible, Interoperable, Reusable
Read more: https://t.co/YvcTB7sUm5
We participate in an open access agreement with the publisher PLOS. The agreement covers 7 PLOS journals.
Articles accepted for publication as of 1 January 2025 are eligible for the deal.
More info: https://t.co/4j7Qy9NWqU
We have opened an account on BlueSky!
But we will still remain active on X for the time being, because still many UMCG employees are present here.
Just out of curiosity:
- What do you think of BlueSky?
- Have you considered switching? Or are you too attached to X?
The result of our HappyOrNot survey about the study places: a large majority is happy or even very happy with it!
And we are happy with that 😊
Want to know more about the results? See: https://t.co/QNH8HBQADX
UMCG-affiliated journal editors can apply for a grant from the national Diamond Open Access fund!
Diamond open access, where neither readers nor authors bear any costs, is one of the possible alternatives to the current publication system.
Read more: https://t.co/yexzceAdEN
Since September, the new Anda Kerkhoven Centre has been in use.
But who was Anda Kerkhoven? What is so sustainable about the building? And how is Healthy Ageing put into practice in this building? Read about it in this fun magazine: https://t.co/vao22OckJ8
The UG and UMCG have introduced a public engagement seed fund as part of the Open Science programme.
The third round of the fund is now open. The deadline for applications is 27 November at 4 p.m.
Read more: https://t.co/MmgbWPRNSJ
Read our latest newsletter about open science
https://t.co/hn7uBBkNDD
With:
- Publisher deals quota
- New round Public Engagement Seed Fund
- Podcast ‘Open Science Bites’ with Laura Postma
- UMCG Symposium ‘Patients in Research’
Important for researchers and students UMCG/RUG:
Our RefWorks license ends on January 1, 2026.
After April 2025, the RefWorks Word plugin will no longer be available.
Our advice: switch to EndNote as soon as you finish your current manuscript!
Read more: https://t.co/PnF1LjBOWM
Important for authors!
We expect the 2024 quota for author discounts to be reached soon at these publishers:
- Lippincott Williams & Wilkins
- Springer Nature
- Taylor & Francis
- Oxford UP
Read here what that means for you as an author:
https://t.co/2Ixi0mosU0